[{"Assets_0_Q1_USD":749369000.0,"CommonStockSharesOutstanding_0_Q1_shares":121527320.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-30256000.0,"NetIncomeLoss_5_Q1_USD":-243100000.0,"NetIncomeLoss_1_Q1_USD":-31586000.0,"StockholdersEquity_0_Q1_USD":681228000.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]